MedAnnex

MedAnnex is a biotech company in Edinburgh, United Kingdom, founded in 2009. It has raised $13.8M across 1 round, most recently a $13.8M Series B in August 2019.

Home page

Headquarters
Edinburgh
Employees
11–50
Founded
2009
Business Model
B2B
Total Funding
$13.8M
Last Round
$13.8M Series BAug 2019
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Medannex is pioneering the targeting of annexin-A1 to provide powerful new treatment options for people impacted by cancers and autoimmune diseases. Annexin-A1 drives cancer cell growth and migration and also plays a key role in the development of several autoimmune conditions. Extensive pre-clinical data demonstrate that its first-in-class monoclonal antibody therapeutic (MDX-124) effectively blocks the action of annexin-A1, and a Phase 1b clinical study is under way in cancer patients, with further autoimmune studies in preparation.

Summary

It lists 11–50 employees. It has raised $13.8M in total across 1 round, most recently a $13.8M Series B round in Aug 2019. Investors include Morningside Group and Scottish Enterprise.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BAug 2019
$13.8M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MedAnnex on Indexed.vc
<a href="https://indexed.vc/companies/medannex"><img src="https://indexed.vc/api/badge/company/medannex" alt="MedAnnex on Indexed.vc" width="260" height="76" /></a>